Virender Kumar Ph.D.
Virender Kumar Ph.D.
Verified email at unmc.edu
Title
Cited by
Cited by
Year
miRNA profiling in pancreatic cancer and restoration of chemosensitivity
S Singh, D Chitkara, V Kumar, SW Behrman, RI Mahato
Cancer letters 334 (2), 211-220, 2013
832013
Codelivery of small molecule hedgehog inhibitor and miRNA for treating pancreatic cancer
V Kumar, G Mondal, P Slavik, S Rachagani, SK Batra, RI Mahato
Molecular pharmaceutics 12 (4), 1289-1298, 2015
732015
Chemosensitization and inhibition of pancreatic cancer stem cell proliferation by overexpression of microRNA-205
AK Chaudhary, G Mondal, V Kumar, K Kattel, RI Mahato
Cancer letters 402, 1-8, 2017
712017
MicroRNAs in the pathogenesis and treatment of progressive liver injury in NAFLD and liver fibrosis
Q Su, V Kumar, N Sud, RI Mahato
Advanced Drug Delivery Reviews 129, 54-63, 2018
642018
Challenges and recent advances in medulloblastoma therapy
V Kumar, V Kumar, T McGuire, DW Coulter, JG Sharp, RI Mahato
Trends in pharmacological sciences 38 (12), 1061-1084, 2017
562017
Micellar delivery of cyclopamine and gefitinib for treating pancreatic cancer
D Chitkara, S Singh, V Kumar, M Danquah, SW Behrman, N Kumar, ...
Molecular pharmaceutics 9 (8), 2350-2357, 2012
502012
Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis
V Kumar, G Mondal, R Dutta, RI Mahato
Biomaterials 76, 144-156, 2016
472016
Nanomedicines of Hedgehog inhibitor and PPAR-γ agonist for treating liver fibrosis
V Kumar, V Mundra, RI Mahato
Pharmaceutical research 31 (5), 1158-1169, 2014
422014
Delivery and targeting of miRNAs for treating liver fibrosis
V Kumar, RI Mahato
Pharmaceutical research 32 (2), 341-361, 2015
382015
EGFR-targeted polymeric mixed micelles carrying gemcitabine for treating pancreatic cancer
G Mondal, V Kumar, SK Shukla, PK Singh, RI Mahato
Biomacromolecules 17 (1), 301-313, 2016
352016
Design, synthesis and biological evaluation of novel hedgehog inhibitors for treating pancreatic cancer
V Kumar, AK Chaudhary, Y Dong, HA Zhong, G Mondal, F Lin, V Kumar, ...
Scientific reports 7 (1), 1-15, 2017
282017
Pharmacokinetics and biodistribution of polymeric micelles containing miRNA and small-molecule drug in orthotopic pancreatic tumor-bearing mice
V Kumar, V Mundra, Y Peng, Y Wang, C Tan, RI Mahato
Theranostics 8 (15), 4033, 2018
222018
Biodistribution of self-assembling polymer–gemcitabine conjugate after systemic administration into orthotopic pancreatic tumor bearing mice
K Kattel, G Mondal, F Lin, V Kumar, RI Mahato
Molecular pharmaceutics 14 (5), 1365-1372, 2017
222017
Impact of miRNA-mRNA profiling and their correlation on medulloblastoma tumorigenesis
RIM Vinod Kumar, Virender Kumar, Amit Kumar Chaudhary, Donald W. Coulter ...
Molecular Therapy: Nucleic Acid, 2018
202018
Pharmacokinetics and biodistribution of GDC-0449 loaded micelles in normal and liver fibrotic mice
R Dutta, V Kumar, Y Peng, RE Evande, JL Grem, RI Mahato
Pharmaceutical research 34 (3), 564-578, 2017
142017
Therapeutic Potential of OMe-PS-miR-29b1 for treating Liver Fibrosis
RIM Virender Kumar, Vinod Kumar, Jiangtao Luo
Molecular Therapy, 2018
132018
Polysubstituted 2-aminoimidazoles as anti-biofilm and antiproliferative agents: Discovery of potent lead
RK Gill, V Kumar, SCA Robijns, HPL Steenackers, EV Van der Eycken, ...
European journal of medicinal chemistry 138, 152-169, 2017
132017
Systemic delivery of nanoparticle formulation of novel tubulin inhibitor for treating metastatic melanoma
V Mundra, Y Peng, V Kumar, W Li, DD Miller, RI Mahato
Drug delivery and translational research 5 (3), 199-208, 2015
132015
Nanoparticulate delivery of potent microtubule inhibitor for metastatic melanoma treatment
J Bariwal, V Kumar, H Chen, RS Bhattarai, Y Peng, W Li, RI Mahato
Journal of Controlled Release 309, 231-243, 2019
112019
Redox-responsive nanoplatform for codelivery of miR-519c and gemcitabine for pancreatic cancer therapy
X Xin, V Kumar, F Lin, V Kumar, R Bhattarai, VR Bhatt, C Tan, RI Mahato
Science advances 6 (46), eabd6764, 2020
92020
The system can't perform the operation now. Try again later.
Articles 1–20